Ceforanide
Appearance
(Redirected from C20H21N7O6S2)
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Intramuscular |
ATC code | |
Pharmacokinetic data | |
Protein binding | 80.6% |
Metabolism | Nil |
Elimination half-life | 2.6 to 2.98 hours |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
NIAID ChemDB | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H21N7O6S2 |
Molar mass | 519.55 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Ceforanide is a second-generation cephalosporin antibiotic.[citation needed]
See also
[edit]References
[edit]External links
[edit]- Crowle A, Sbarbaro J, May M (1988). "Effects of isoniazid and of ceforanide against virulent tubercle bacilli in cultured human macrophages". Tubercle. 69 (1): 15–25. doi:10.1016/0041-3879(88)90036-0. PMID 3140456.
- Campoli-Richards D, Lackner T, Monk J (1987). "Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy". Drugs. 34 (4): 411–37. doi:10.2165/00003495-198734040-00001. PMID 3315624. S2CID 242440792.
- Cone L, Barton S, Woodard D (1987). "Treatment of scleroma with ceforanide". Arch Otolaryngol Head Neck Surg. 113 (4): 374–6. doi:10.1001/archotol.1987.01860040036012. PMID 3814386.